The new 20g size is now available for only $60. Prescribe today.

Winner-2020 Winner-2020

Altreno named a top skincare product of 2020 by Shape Magazine!

An expert panel of dermatologists and editors reviewed hundreds of skincare products, and Altreno was a winner!

Patient benefits

Altreno Lotion can be applied at any time — day or night, once daily. It can even be worn under makeup.6 It’s ideal for active and successful women who favor premium products.

Star

Over

97%

of physicians agreed that
the lotion vehicle:

Star
  • Absorbs quickly and easily into the skin (99.7%)
  • Leaves no residue (98.3%)
  • Provides light-weight moisturization (97.1%)
  • Does not make my skin feel greasy (99.7%)
  • Has no unpleasant odor (98.6%)
  • Is not tacky to the touch (99.1%)

Results from a perception survey of healthcare professionals who tried the lotion vehicle. A total of 349 prescribers with practices in the U.S.A. tried the Altreno lotion vehicle and completed the survey.7

References

  1. Data on file. Ortho Dermatologics.
  2. Altreno Lotion [package insert]. Bridgewater, NJ: Ortho Dermatologics.
  3. Wang Y, Viennet C, Jeudy A, Fanian F, He L, Humbert P. Assessment of the efficacy of a new complex antisensitive skin cream. J Cosmet Dermatol. 2018;17(6):1101-1107.
  4. Dermatologists’ top tips for relieving dry skin. American Academy of Dermatology website. https://www.aad.org/public/skin-hair-nails/skin-care/dry-skin. Accessed March 20, 2020.
  5. Morganti P, Randazzo SD, Cardillo A. Role of insoluble and soluble collagen as skin moisturizer. J Appl Cosmetol. 1986;4:141-152.
  6. Data on File. A split-face, controlled clinical trial to evaluate the compatibility of an acne lotion with foundation makeup. 2019.
  7. Data on File. Ortho Dermatologics. Perception survey: Healthcare professionals. 2019.

INDICATIONS AND USAGE
Altreno (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.

IMPORTANT SAFETY INFORMATION
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.

Important safety information
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.

IMPORTANT SAFETY INFORMATION
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.

INDICATIONS AND USAGE
Altreno (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.

IMPORTANT SAFETY INFORMATION
Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.

Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.

Ultraviolet Light and Environmental Exposure: Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.

Fish Allergies: Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.

Adverse Reactions: The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).

Nursing Women: It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.

To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

Please click here for full Prescribing Information.